FDA Inspection
OneBlood, Inc.OneBlood, Inc. – FDA Inspection, Mar 23, 2023
Record Details
This FDA Inspection record concerns OneBlood, Inc., with an inspection on March 23, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 3cdf69a6-2397-4741-b927-490fba121d93
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1204182
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of OneBlood, Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| January 23, 2026 | NAI | Blood and Blood Products | |
| April 18, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 3, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 23, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 12, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for OneBlood, Inc.
- FDA Inspection 1303580 - 2026-01-23
- FDA Inspection 1086790 - 2019-04-18
- FDA Inspection 1012284 - 2017-02-03
- FDA Inspection 932398 - 2015-06-23
- FDA Inspection 811064 - 2012-12-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.